Anticancerous effect of rutin against HPV- C33A cervical cancer cells via G0/G1 cell cycle arrest and apoptotic induction.
Clicks: 253
ID: 33119
2019
Nowadays the potential therapeutic role of various bioflavonoids including Curcumin, Luteolin and Resveratrol has currently been well-documented in a vast range of fatal complications including synaptic failure and cancers. These bioflavonoids are widely being implemented in the treatment of various cancers as these possess anti-cancerous, anti-oxidant and anti-inflammatory properties. Moreover, these are also used as a better alternative to conventional therapies since; these are non-toxic to cells and having no or least side effects. Notably, the pertinent therapeutic role of Rutin in cervical cancer is still unsettled however its anti-cancerous role has already been reported in other cancers including prostate and colon cancer. Rutin (Vitamin P or Rutoside) is a polyphenolics flavonoid exhibiting multi-beneficial roles against several carcinomas.Despite the evidence for its several biological activities, the anticancer effects of Rutin on human cervical cancer (C33A) cells remain to be explored. In this study, the anticancer potential of Rutin was investigated by employing the key biomarkers such as nuclear condensation reactive oxygen species (ROS), apoptosis, and changes in mitochondrial membrane potential (MMP).Our findings showed that Rutin treatment reduced the cell viability, induced significant increase in ROS production and nuclear condensation in dose dependent manner. Moreover, Rutin provoked apoptosis by inducing decrease in MMP and activation of caspase-3. Cell cycle analysis further confirmed the efficacy of Rutin by showing cell cycle arrest at G0/G1 phase.Thus, our study is envisaged to open up interests for elucidating Rutin as an anti-cancerous agent against cervical cancer.
Reference Key |
khan2019anticancerousendocrine
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Khan, Fahad;Pandey, Pratibha;Upadhyay, Tarun Kumar;Jafri, Asif;Jha, Niraj Kumar;Mishra, Rashmi;Singh, Vineeta; |
Journal | endocrine, metabolic & immune disorders drug targets |
Year | 2019 |
DOI | 10.2174/1871530319666190806122257 |
URL | |
Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.